Lichen China appoints Robert Bodenstein to its Board as Independent Director

– CHINA, Jinjiang City –  Lichen China Limited (NASDAQ: LICN), a dedicated financial and taxation service provider in China, announced the appointment of Robert Bodenstein to its Board as an Independent Director, effective February 26, 2024.

Mr. Bodenstein will also join the Nominating, Compensation, and Audit Committees.

About Robert Bodenstein

Robert Bodenstein, with over 40 years of experience in the management consulting industry, serves as the Chair of the International Council of Management Consulting Institutes, a global alliance of management consulting institutes, recognized by the United Nations Economic and Social Council as a non-governmental organization with special consultative status, as the Chair of the Chamber of Commerce Austria Consulting and Information Division, an organization that covers management consulting, IT, and communication business, and also as the Chair of the committee under the ISO TC 280 (Management Consultancy), which works with member countries in setting up the standard ISO 20700:2017 Management Consulting Services.

About Lichen China Limited

Lichen China Limited focuses on providing financial and taxation solution services, education support services, and software and maintenance services under its “Lichen” brand. In recognition of the Company’s expertise and experience in the financial and taxation solution services industry for over 18 years, the Company has built up its reputation as a dedicated financial and taxation solution services provider of professional and high-quality services in China.

For more information: https://ir.lichenzx.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.